The Nucleovox Newsletter

Swarna Prashan — gold-based immunity drops given to infants and children in Ayurveda — is now marketed globally as an 'ancient vaccination technique.' A 2022 systematic review found only 5 qualifying RCTs in 21 years of literature. A 2024 RCT (n=120) showed real benefit for recurrent respiratory infections. But the broader category of Ayurvedic bhasma products has documented, FDA-flagged heavy metal contamination risks in paediatric products. Parents deserve both facts.

Magnesium is the most searched mineral supplement globally in 2025. An estimated 2.4 billion people fail to meet the recommended intake. A 2025 RCT (n=155, the largest placebo-controlled magnesium sleep trial to date) confirmed bisglycinate improved sleep quality. A 2024 systematic review of 15 studies found generally positive results for sleep and anxiety. Here is what the evidence actually shows — and what it does not.

"Nature's Ozempic" is one of the most searched supplement phrases globally in 2025. A 2024 meta-analysis of 50 RCTs (n=4,150) shows berberine reduces fasting glucose by 0.59 mmol/L and LDL-C by 0.30 mmol/L. Semaglutide produces 15.2% body weight loss at 104 weeks and a 20% reduction in major cardiovascular events. Both facts belong in the same conversation.

A 2025 meta-analysis of 12 RCTs confirms berberine reduces fasting glucose, LDL-C, and triglycerides; absolute quantitative metagenomics resolves a decade-long debate about its gut microbiome effects.

A 2025 SHIME model study confirmed Triphala increases Akkermansia muciniphila while its ellagic acid is converted to urolithins — but only if you carry the right gut bacteria.

In a 82-patient RCT, andrographolide cut day-7 CRP from 18.4 to 5.8 mg/L (p=0.019) — but the gap closed by day 14, raising questions about its temporal role.

FDA-approved in January 2025, suzetrigine selectively blocks NaV1.8 in peripheral pain neurons with >31,000-fold selectivity — matching opioid efficacy without addiction risk.

You take your turmeric capsule every morning. Your friend swears by berberine. Someone else drinks green tea extract daily. But what if a large fraction of those carefully chosen compounds never actually reaches your bloodstream in a form the body can use? This is the bioavailability problem — one of the most significant and least discussed gaps between what herbal science promises and what actually happens inside the human body. Nanotechnology is now offering scientifically validated answers.

How modern neuroscience is catching up to an ancient insight, and what Triphala, Ashwagandha, and Brahmi have to do with it.

How the golden compound in turmeric modulates NF-kB pathways and what modern clinical trials say.

A deep dive into clinical trials on Ashwagandha effects on cortisol, anxiety, and sleep.

How gene editing is being used to enhance medicinal compound production in herbs like Ashwagandha and Brahmi.